Dr. David Wortley is a Fellow of the Royal Society of Arts, a futurologist and a thought-leader on disruptive technologies such as Artificial Intelligence and the Metaverse. He is a motivational speaker and professional member of the Professional Speaking Association. He has been a keynote speaker at over 100 international conferences over the last 20 years. He is a Vice President of the International Society for Digital Medicine and a respected expert in digital therapeutics and lifestyle medicine. He is also a non-Executive Director of the World Lifestyle Medicine Education Services (WLMES).

Dr Atul Dwivedi got his PhD from Zhengzhou university (World ranking :590, National ranking 47), China. He served as Assistant Professor, Associate Professor, and Visting Faculty in different universities of China. After completing MBBS degree from Zhengzhou university, he pursued three years Residency in orthopaedic Surgery from The first Affiliated Hospital of Zhengzhou university. He has been invited as a speaker in several international conferences. He sits as editorial board member / Advisory Board member/ reviewer in more than sixty renowned International Indexed Journals. He Authored and coauthored several research papers and book in indexed Journals. His several publication are indexed in semantic scholar, Google scholar, dimension data base and core collection of web of science (Clarivate Analytics), Index Copernicus, CNKI (China National Knowledge Infrastructure) Naver Academic (academic.naver.com), George M. Manuel Library, Carolina University (USA), (Malaysia), Majmaah University,Index Medicus, United States VHL (Virtual Health Library), Brazil. He coauthored and published a book in Germany, which is available on more than 20 online portals worldwide.

Dr Darwin Eton is a Distinguished Fellow of the Society of Vascular Surgery. In 1999 he initiated a research effort to promote neovascularization in patients with Chronic Ischemia in 1999 at University of Miami where he was Professor and Chief of Vascular Surgery. He further advanced the project while Professor of Surgery at the University of Chicago. This project won the Cures Within Reach Award in 2016. The proceeds were used to fund a confirmatory study at University of Illinois at Chicago, where Dr Eton held a Voluntary Professor appointment in Surgery. He started Vasogenesis Inc (Boston MA), where he presently serves as the Chief Research and Medical Officer. He has authored 46 peer review publications, many book chapters, and textbooks in Vascular Surgery, and has been an invited speaker in USA and internationally. He graduated from the Massachusetts Institute of Technology (B.Sc, MSc.) in 1978 and New York University Medical School (M.D.) in 1982. Over the last decade he developed a special interest in how physics contributes to the understanding of cell evolution.

Dr. Y. James Kang is the Chief Scientist, Tasly Biopharmaceutical Company, Tianjin; Professor and Director of the Regenerative Medicine Research Center at Sichuan University West China Hospital; Director of Sichuan Regenerative Medicine Research and Technology Center; and Emeritus Professor, University of Louisville, Louisville, KY, USA. Dr. Kang received his Ph.D. in Toxicology and Cell Biology at Iowa State University in 1989 and completed postdoctoral training in Biochemistry and Molecular Biology at Cornell University Medical Center in 1991. He was Assistant Professor of Pharmacology and Toxicology, University of North Dakota School of Medicine (1991-1996); Associate Professor and University Scholar (1996-2001) and Professor and Distinguished University Scholar (2001-2017) in Medicine, Pharmacology and Toxicology, University of Louisville School of Medicine. He served several US-NIH study sections from 1997 to 2006, and other US federal agencies including USDA, US-EPA and US-Veterans Administrations from 1996 to 2005. He was an elected Fellow of the Academy of Toxicological Sciences since 2001, and he was the Editor-in-Chief of Cardiovascular Toxicology (2001-2022). His research interests are in regenerative medicine, focusing on MSCs, tissue injury signaling and organ rejuvenation. He made a major breakthrough in 3D bio-printing of stromal cell-based vascular graft for human implantation, leading the field of MSCs in organ rejuvenation.

Prof. Stefan Bittmann, M.A. is a renowned German board-certified Pediatrician and Professor of Pediatrics at the School of Medicine, Shangluo Vocational and Technical College, University in China. He is also affiliated with the Department of Pediatrics at the Medical and Financial Center Gronau in Germany. Prof. Bittmann is known for his significant contributions to Pediatrics and his role as an international medical consultant. He has actively promoted medical science and cooperation between China and Germany and made notable contributions to global health initiatives and research, especially in the field of Pediatrics.

Dr. Maria Dalamagka, MD, MSc, PhD, is a consultant anesthesiologist at the General Hospital of Larisa, Greece. Her expertise spans anesthesia management in pediatric, autistic, surgical, orthopedic, urological, obstetric, and otorhinolaryngological cases, as well as emergency treatments. During the COVID-19 pandemic, she played a critical role in managing ICU patients in the operating room recovery unit. Additionally, she has explored acupuncture as an early intervention for chronic pain. Dr. Dalamagka is an active editor for various medical journals and has contributed significantly to the field through her research and editorial work.

Prof. Joan-Lluis Vives-Corrons, MD, PhD, is Emeritus Professor of Hematology at the University of Barcelona and Honorary Researcher at the Josep Carreras Leukaemia Research Institute. He holds an MD and PhD in Medicine from the University of Barcelona, where he led the Red Blood Cell Pathology Unit and served as Head of the Hematology Laboratory Department for over three decades. His research has focused on the molecular and functional characterization of hereditary hemolytic anemias, including membranopathies, enzymopathies, and hemoglobinopathies He has coordinated several international initiatives, including the European Network for Rare and Congenital Anaemias (ENERCA), and currently chairs the Scientific Board of the Rare Anemias International Network (RAIN). Prof. Vives-Corrons has authored over 300 scientific publications and played a key role in the development of the ERN-EuroBloodNet for rare hematological diseases. He is a member of various scientific societies, including EHA and ASH, and has received multiple recognitions for his lifelong commitment to rare anemia research.